ArticleOncoTargets and therapy2025

Patients with Advanced Non-Small Cell Lung Cancer and the EGFR Exon 19 Deletion p.L747 Benefit from Chemotherapy and First-Generation Tyrosine Kinase Inhibitors Compared with Patients with p.E746.

Maojing Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.